Literature DB >> 18344019

Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolites.

R Hardeland1.   

Abstract

In its role as a pineal hormone, melatonin is a pleiotropic, nocturnally peaking and systemically acting chronobiotic. These effects are largely explained by actions via G protein-coupled membrane receptors found in the suprachiasmatic nucleus, but also in numerous other sites. Nuclear (ROR/RZR), cytoplasmic (quinone reductase-2, calmodulin, calreticulin) and mitochondrial binding sites and radical-scavenging properties contribute to the actions of melatonin. Regulation of pineal melatonin biosynthesis is largely explained by control mechanisms acting on arylalkylamine N-acetyltransferase, at the levels of gene expression and/or enzyme stability influenced by phosphorylation and interaction with 14-3-3 proteins. Melatonin is not only a hormone but is also synthesized in numerous extrapineal sites, in which it sometimes attains much higher quantities than in the pineal and the circulation. It is also present in many taxonomically distant groups of organisms, including bacteria, fungi, and plants. Moreover, melatonin is a source of bioactive metabolites, such as 5-methoxytryptamine, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine and N(1)-acetyl-5-methoxykynuramine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18344019     DOI: 10.1007/s00018-008-8001-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  54 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

3.  Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors.

Authors:  Anastasia Renzi; Shannon Glaser; Sharon Demorrow; Romina Mancinelli; Fanyin Meng; Antonio Franchitto; Julie Venter; Mellanie White; Heather Francis; Yuyan Han; Domenico Alvaro; Eugenio Gaudio; Guido Carpino; Yoshiyuki Ueno; Paolo Onori; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-07-14       Impact factor: 4.052

Review 4.  Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer.

Authors:  Brittney Jung-Hynes; Russel J Reiter; Nihal Ahmad
Journal:  J Pineal Res       Date:  2010-01       Impact factor: 13.007

5.  Bivalve mollusc circadian clock genes can run at tidal frequency.

Authors:  Damien Tran; Mickael Perrigault; Pierre Ciret; Laura Payton
Journal:  Proc Biol Sci       Date:  2020-01-08       Impact factor: 5.349

6.  2',3'-Cyclic nucleotide 3'-phosphodiesterase as a messenger of protection of the mitochondrial function during melatonin treatment in aging.

Authors:  Yulia Baburina; Irina Odinokova; Tamara Azarashvili; Vladimir Akatov; John J Lemasters; Olga Krestinina
Journal:  Biochim Biophys Acta Biomembr       Date:  2016-11-09       Impact factor: 3.747

Review 7.  Protective roles of melatonin in central nervous system diseases by regulation of neural stem cells.

Authors:  Xin Yu; Zheng Li; Heyi Zheng; Jeffery Ho; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2016-12-12       Impact factor: 6.831

8.  Effects of hypoxia and reoxygenation on the antioxidant defense system of the locomotor muscle of the crab Neohelice granulata (Decapoda, Varunidae).

Authors:  Márcio Alberto Geihs; Marcelo Alves Vargas; Fábio Everton Maciel; Olli Vakkuri; Victor Benno Meyer-Rochow; Silvana Allodi; Luiz Eduardo Maia Nery
Journal:  J Comp Physiol B       Date:  2016-03-19       Impact factor: 2.200

Review 9.  Melatonin, an ubiquitous metabolic regulator: functions, mechanisms and effects on circadian disruption and degenerative diseases.

Authors:  Andreea Iulia Socaciu; Răzvan Ionuţ; Mihai Adrian Socaciu; Andreea Petra Ungur; Maria Bârsan; Angelica Chiorean; Carmen Socaciu; Armand Gabriel Râjnoveanu
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

10.  Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.

Authors:  Yuyan Han; Paolo Onori; Fanyin Meng; Sharon DeMorrow; Julie Venter; Heather Francis; Antonio Franchitto; Debolina Ray; Lindsey Kennedy; John Greene; Anastasia Renzi; Romina Mancinelli; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-11       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.